The city of Urupês in Brazil will start offering the drug tirzepatide, also known as Mounjaro, for free to residents suffering from obesity as part of a local health initiative.
The municipality of Urupês, located in São Paulo, Brazil, has initiated a program to provide the medication tirzepatide, commercially known as Mounjaro, to local residents who are struggling with obesity, beginning Thursday, the 26th. The program is set to offer this treatment free of charge within the municipal health network, aiming to assist approximately 200 patients in a phased manner. Initially, 15 selected patients will receive their first doses on the program's launch day, indicating a structured approach to addressing obesity in the region.
To ensure comprehensive care, the treatment will be supported by a multidisciplinary team that includes endocrinologists, nutritionists, psychologists, physical educators, and social workers. This integrated healthcare model is designed to tackle the complex nature of obesity, which requires more than just medication; it involves behavioral and lifestyle changes. The local administration noted that data from the Food and Nutritional Surveillance System (Sisvan) reveals that around 43% of Urupês' population struggles with some form of overweight, highlighting the urgency of this health initiative.
